$RUN

Lontoh Sonita sold $90K of RUN (indirect holdings)

Lontoh Sonita sold 7,500 indirectly-held shares of Sunrun Inc. (RUN) at $12.00 on 2026-06-11.

Original reporting
SEC EDGAR · Lontoh Sonita
Published Jun 12, 2026, 8:24 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 12, 2026, 8:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$RUN
Neutral
medium confidence
Mentioned
$RUN
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RUNNeutralLow
01

Why it matters

The newest fact is the director’s open-market sale of 7,500 shares at $12.00 on 2026-06-11, reported via Form 4 filed 2026-06-12.

02

Market read

Traders may monitor for follow-on insider activity, but this is not a fundamental corporate event.

03

What to watch

Consider whether there were concurrent insider buys/sales by other insiders and whether the stock had any same-day fundamental news; this filing alone is unlikely to explain broader moves.

Relevance 3/10Novelty 8/10Timing: Filed 2026-06-12; sale executed 2026-06-11

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for Sunrun Inc. (RUN).

Company-level read

Ticker impact

$RUNNeutralMedium confidence
Context

Sunrun director Lontoh Sonita filed an SEC Form 4 selling 7,500 shares at $12.00 on 2026-06-11 (indirect holdings).

Expected impact

Low likelihood of sustained price impact; any reaction is likely muted and short-lived.

Evidence & confidence

The filing is a Form 4 insider transaction with no 10b5-1 plan and a modest dollar value ($90k), which typically has limited predictive power versus earnings/guidance or major corporate events.

Market effects

Minimal; insider sale does not change solar/renewables sector fundamentals.

None indicated.

None indicated.

Counterpoint

No 10b5-1 plan is noted, but insider sales can be driven by diversification/taxes rather than bearish expectations; the size is small relative to typical institutional flows.

Key entities

  • Sunrun Inc.

    Company whose insider transaction is disclosed on Form 4.

  • Lontoh Sonita

    Director reporting an open-market sale of RUN shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$FSLRMed

First Solar Climbs 4% as Truist Buy Call and December Tariff Floor Reset Panel Pricing Outlook; Enphase Energy and Sunrun Hold Flat

First Solar (FSLR) stock rose 4% to $186.21 after a Truist upgrade to Buy with a $270 price target, citing improved pricing and valuation. The U.S. Department of Commerce's Section 232 trade decision sets a minimum import price for foreign solar panels, benefiting First Solar. Enphase (ENPH) and Sunrun (RUN) stocks remained flat. First Solar's thin-film technology and U.S. manufacturing position it favorably against competitors.

$RUNHigh

Goldman Sachs Cut Its Sunrun Target. It Still Sees [44%] Upside

Goldman Sachs and Citi reduced their price targets for Sunrun (RUN) to $11 and $14, respectively, while maintaining Buy ratings. Analysts anticipate a decline in Sunrun's EPS from $1.71 in 2025 to $1.00 by 2027. Sunrun's stock closed at $7.61 on Oct. 7, a 52-week low. The cuts reflect lower expectations for near-term growth and cash generation.

$RUNMed

Why is Sunrun stock sliding today?

Sunrun (RUN) stock fell 2.0% to $7.46 in pre-market trading, continuing a downtrend after price target cuts from Goldman Sachs and Citi, citing lower near-term growth expectations. The stock hit a 52-week low of $7.42, down 62% over the past year. Analysts maintained Buy ratings but reduced targets to $11 and $14, respectively. A large options trade suggests hedging against further downside. The broader market decline and policy uncertainty also weighed on the stock.